Gallic acid treats dust-induced NAFLD in rats by improving the liver’s anti-oxidant capacity and inhibiting ROS/NFκβ/TNFα inflammatory pathway. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.